Form D · Biotechnology

Scythian Biosciences Inc.

Calgary, A0 · CIK 0001664115

Offering snapshot reported May 31, 2016 · SEC filing

Reported sold
$170K
Offering amount: $170K
Investors reported
12
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 20, 2015
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$85.1K$170KMay 31, 2016: $170,228.00May 31, 2016May 31, 2016: $170,228.00May 31, 2016

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 31, 2016Initial$170,228No comparison12SEC filing
May 31, 2016Initial$71,868No comparison10SEC filing
May 31, 2016Amendment$170,228$0vs May 31, 201612SEC filing
Jan 22, 2016Initial$121,129No comparison7SEC filing
Jan 22, 2016Initial$25,900No comparison1SEC filing
Jan 22, 2016Initial$38,923No comparison6SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-264085
U.S. dollar amounts are based on the Bank of Canada noon rate of exchange reported on July 20, 2015, which was Cdn$1.2982=US$1.00.

Source: Form D, filed May 31, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Allan Cohen Director
Mo Fazil Director, Executive
Jonathan Gilbert Director, Executive
Jerome Gilbert Director
Harvey Lalach Director, Executive
Michael Petter Director
David Schrader Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1250 639 5 Th Avenue Sw
Calgary, A0, T2P 0M9